{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:03:31Z","timestamp":1771477411399,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The authors sought to determine if universal face mask guidelines implemented during the coronavirus disease 2019 pandemic significantly influenced the incidence of endophthalmitis following intravitreal injections (IVI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective cohort study reviewed the electronic health records from a retina-only practice located in Michigan. This study evaluated patients receiving IVIs over two distinct time periods of April 2019 to March 2020 and April 2020 to March 2021, which comprised our unmasked and masked groups, respectively. The authors then calculated the incidence of endophthalmitis following IVI and evaluated the cases of post-injection endophthalmitis for both time periods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 121,384 IVIs performed over the 2-year period of interest. Of these, 63,114 were unmasked and 58,270 were masked patient encounters. A total of 46 post-injection endophthalmitis cases were identified. Of these, 29 cases were from the unmasked period and 17 were from the masked period. This resulted in an incidence of endophthalmitis of 0.046% and 0.038% in the masked and unmasked groups, respectively. This difference did not rise to the level of statistical significance (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.1336).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study suggests that the incidence of post-injection endophthalmitis was not influenced by the implementation of ophthalmologist-patient face masking after IVI during the coronavirus disease 2019 pandemic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004072","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T19:00:09Z","timestamp":1708110009000},"page":"1203-1208","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["PATIENT\u2013PHYSICIAN FACE MASKING'S INFLUENCE ON THE POST-INTRAVITREAL INJECTION ENDOPHTHALMITIS"],"prefix":"10.1097","volume":"44","author":[{"given":"Conner","family":"Liddle","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Capone","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"},{"name":"Department of Ophthalmology, Associated Retinal Consultants, Royal Oak, Michigan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Trese","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"},{"name":"Department of Ophthalmology, Associated Retinal Consultants, Royal Oak, Michigan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/CMR.00113-16","article-title":"Bacterial and fungal endophthalmitis","volume":"30","author":"Durand","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2015.04.013","article-title":"Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome","volume":"160","author":"Dossarps","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/IAE.0b013e318221594a","article-title":"Endophthalmitis after intravitreal injection: the importance of viridans streptococci","volume":"31","author":"Chen","year":"2011","journal-title":"Retina"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/IAE.0b013e31820a67e4","article-title":"Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies","volume":"31","author":"McCannel","year":"2011","journal-title":"Retina"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jcjo.2017.04.016","article-title":"Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept","volume":"52","author":"Forooghian","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000001583","article-title":"Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents with and without topical antibiotic prophylaxis","volume":"38","author":"Reibaldi","year":"2018","journal-title":"Retina"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.oret.2018.09.013","article-title":"Predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength","volume":"3","author":"Stem","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00417-013-2274-y","article-title":"Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask","volume":"251","author":"Shimada","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archophthalmol.2011.227","article-title":"Bacterial dispersal associated with speech in the setting of intravitreous injections","volume":"129","author":"Wen","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/IAE.0000000000000399","article-title":"Intravitreal injection technique and monitoring: updated guidelines of an expert panel","volume":"34","author":"Avery","year":"2014","journal-title":"Retina"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcjo.2021.06.015","article-title":"Impact of patient face mask use on endophthalmitis after intravitreal anti-VEGF injections","volume":"57","author":"H\u00e9bert","year":"2022","journal-title":"Can J Ophthalmol"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.ophtha.2021.05.010","article-title":"The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections","volume":"128","author":"Patel","year":"2021","journal-title":"Ophthalmology"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/jcm11030876","article-title":"Safety measures for maintaining low endophthalmitis rate after intravitreal anti-vascular endothelial growth factor injection before and during the COVID-19 pandemic","volume":"11","author":"Tanaka","year":"2022","journal-title":"J Clin Med"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajo.2020.08.013","article-title":"The impact of physician face mask use on endophthalmitis after intravitreal anti-vascular endothelial growth factor injections","volume":"222","author":"Patel","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R16-20250605","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000004043","article-title":"No effect of real-world universal face masking on post-intravitreal injection endophthalmitis rate at a single tertiary academic center","author":"Haliyur","year":"2024","journal-title":"Retina"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3928\/23258160-20210528-04","article-title":"Trends in endophthalmitis associated with intravitreal injection of anti-VEGF agentsat a tertiary referral center","volume":"52","author":"Reyes-Capo","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ophtha.2021.01.007","article-title":"Face masks and bacterial dispersion toward the periocular area","volume":"128","author":"Raevis","year":"2021","journal-title":"Ophthalmology"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"333","DOI":"10.12788\/cutis.0412","article-title":"Proper use and compliance of facial masks during the COVID-19 pandemic: an observational study of hospitals in New York city","volume":"108","author":"Loyal","year":"2021","journal-title":"Cutis"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19-related concerns\u2014United States, June 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.3390\/ijerph19169818","article-title":"Prevalence, causes, and adverse clinical impact of delayed presentation of non-COVID-19-related emergencies during the COVID-19 pandemic: findings from a multicenter observational study","volume":"19","author":"Alshahrani","year":"2022","journal-title":"Int J Environ Res Public Health"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:01:45Z","timestamp":1749142905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004072","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}